Polyrizon Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- Polyrizon Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Ra'anana
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- PLRZ
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001893645
Board of directors
-
Asaf Itzhaik · DirectorSince 2026
-
Liat Sidi · DirectorSince 2026
-
Liron Carmel · DirectorSince 2026
-
Oz Adler · DirectorSince 2026
-
Tidhar Turgeman · Director · Chief Technology OfficerSince 2026
-
Tomer Izraeli · Director · Chief Executive OfficerSince 2026
-
Yehonatan Zalman Vinokur · DirectorSince 2026
Chief executives
Tomer Izraeli
· Chief Executive Officer
Since March 2026
Board connections
4 of this board's directors also sit on 5 other boards.
- via Asaf Itzhaik and Liat Sidi
- via Liron Carmel and Oz Adler
- via Oz Adler
- via Liat Sidi
- via Oz Adler
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $132,642
- 6 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Tomer Izraeli Director, Officer (Chief Executive Officer) | Open-market sale | −500 | $11.85 | $5,925 |
| Mar 31, 2026 | Liron Carmel Director | Open-market sale | −942 | $12.36 | $11,643 |
| Mar 31, 2026 | Oz Adler Director | Open-market sale | −3,292 | $12.05 | $39,669 |
| Mar 30, 2026 | Liron Carmel Director | Open-market sale | −100 | $11.00 | $1,100 |
| Mar 30, 2026 | Tomer Izraeli Director, Officer (Chief Executive Officer) | Open-market sale | −3,900 | $10.90 | $42,510 |
| Mar 30, 2026 | Tidhar Turgeman Director, Officer (Chief Technology Officer) | Open-market sale | −2,917 | $10.90 | $31,795 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.